Hongxia Yan; Hongfei Duan; Xiaoxu Han; Jin Sun; Qingtao Liang; Yan Zhao; Zhenglai Ma; Ning Ding; Meixin Ren; Taiyi Jiang; Tong Zhang; Bin Su; Hongxia Yan; Hongfei Duan; Xiaoxu Han; Jin Sun; Qingtao Liang; Yan Zhao; Zhenglai Ma; Ning Ding; Meixin Ren; Taiyi Jiang; Tong Zhang; Bin Su

doi:10.46234/ccdcw2025.186

[1]

Yin YJ. Chinese guidelines for the diagnosis and treatment of human immunodeficiency virus infection/acquired immunodeficiency syndrome (2024 edition). Chin Med J 2024;137(22):2654 − 80. https://doi.org/10.1097/cm9.0000000000003383.

[2]

Liu EY, Wang Q, Zhang GQ, Zhou L, Chen MT. Tuberculosis/HIV coinfection and treatment trends — China, 2015−2019. China CDC Wkly 2020;2(48):924 − 8. https://doi.org/10.46234/ccdcw2020.252.

[3]

World Health Organization. Global tuberculosis report 2023. 2023. https://www.who.int/publications/i/item/9789240083851. [2025-6-10].

[4]

Bruchfeld J, Correia-Neves M, Källenius G. Tuberculosis and HIV coinfection. Cold Spring Harb Perspect Med 2015;5(7):a017871. https://doi.org/10.1101/cshperspect.a017871.

[5]

Bell LCK, Noursadeghi M. Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection. Nat Rev Microbiol 2018;16(2):80 − 90. https://doi.org/10.1038/nrmicro.2017.128.

[6]

Dolla CK, Dhanaraj B, Chandrasekaran P, Selvaraj S, Menon PA, Thiruvengadam K, et al. Prevalence of bacteriologically confirmed pulmonary tuberculosis and associated risk factors: a community survey in Thirvallur District, south India. PLoS One 2021;16(10):e0247245. https://doi.org/10.1371/journal.pone.0247245.

[7]

Sun J, Han XX, Yan HX, Zhang X, Jiang TY, Zhang T, et al. Advances in technology for the laboratory diagnosis of individuals with HIV/AIDS coinfected with Mycobacterium tuberculosis. Biosaf Health 2024;6(3):133 − 42. https://doi.org/10.1016/j.bsheal.2024.04.003.

[8]

Ortiz-Brizuela E, Apriani L, Mukherjee T, Lachapelle-Chisholm S, Miedy M, Lan ZY, et al. Assessing the diagnostic performance of new commercial interferon-γ release assays for Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Clin Infect Dis 2023;76(11):1989 − 99. https://doi.org/10.1093/cid/ciad030.

[9]

Li K, Yang CY, Jiang ZC, Liu SX, Liu J, Fan CQ, et al. Quantitative investigation of factors relevant to the T cell spot test for tuberculosis infection in active tuberculosis. BMC Infect Dis 2019;19(1):673. https://doi.org/10.1186/s12879-019-4310-y.

[10]

Aabye MG, Ruhwald M, Praygod G, Jeremiah K, Faurholt-Jepsen M, Faurholt-Jepsen D, et al. Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients. Eur Respir J 2010;36(6):1488 − 90. https://doi.org/10.1183/09031936.00039010.

[11]

Pan LP, Huang ML, Jia HY, Deng GF, Chen Y, Wei RR, et al. Diagnostic performance of a novel CXCL10 mRNA release assay for Mycobacterium tuberculosis infection. Front Microbiol 2022;13:825413. https://doi.org/10.3389/fmicb.2022.825413.

[12]

National Health Commission of the People’s Republic of China. The diagnostic criteria for tuberculosis (WS 288-2017). https://www.nhc.gov.cn/wjw/s9491/201712/a452586fd21d4018b0ebc00b89c06254.shtml. [2025-6-10]. (In Chinese).

[13]

Qiu X, Xiong T, Su XJ, Qu Y, Ge L, Yue Y, et al. Accumulate evidence for IP-10 in diagnosing pulmonary tuberculosis. BMC Infect Dis 2019;19(1):924. https://doi.org/10.1186/s12879-019-4466-5.

[14]

Wu X, Zhang LL, Yin LB, Fu YJ, Jiang YJ, Ding HB, et al. Deregulated MicroRNA-21 expression in monocytes from HIV-infected patients contributes to elevated IP-10 secretion in HIV infection. Front Immunol 2017;8:1122. https://doi.org/10.3389/fimmu.2017.01122.

[15]

Tang Y, Yu YH, Wang Q, Wen ZL, Song RX, Li Y, et al. Evaluation of the IP-10 mRNA release assay for diagnosis of TB in HIV-infected individuals. Front Cell Infect Microbiol 2023;13:1152665. https://doi.org/10.3389/fcimb.2023.1152665.

[16]

Tsuboi H, Wakamatsu E, Iizuka M, Nakamura Y, Sugihara M, Suzuki T, et al. Importance of serine727 phosphorylated STAT1 in IFNγ-induced signaling and apoptosis of human salivary gland cells. Int J Rheum Dis 2011;14(1):86 − 91. https://doi.org/10.1111/j.1756-185X.2010.01575.x.

[17]

Henry RT, Jiamsakul A, Law M, Losso M, Kamarulzaman A, Phanuphak P, et al. Factors associated with and characteristic of HIV/tuberculosis Co-infection: a retrospective analysis of SECOND-LINE clinical trial participants. J Acquir Immune Defic Syndr 2021;87(1):720 − 9. https://doi.org/10.1097/qai.0000000000002619.

[18]

Arend SM, van Meijgaarden KE, de Boer K, de Palou EC, van Soolingen D, Ottenhoff THM, et al. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii. J Infect Dis 2002;186(12):1797 − 807. https://doi.org/10.1086/345760.